l9n/ Pennsylvania

2021–2022 Regular Session

House Bill 1238

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Did not become law. It stopped in the House of Representatives's Judiciary Committee on April 20, 2021. The 2021–2022 session has ended.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

4 co-sponsors

Maureen E. Madden, David H. Zimmerman, David M. Delloso, SCOTT CONKLIN

Its course

April 20 to April 20, 2021, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action1 action on 1 day

In the House of RepresentativesApr 20 to Apr 20 · stopped0 days

JudiciaryApr 20 to Apr 20 · stopped0 days

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the House of Representatives Apr 20

  1. Sent to JUDICIARY
All 1 actions, as published